Kyphoplasty Surgery in India
Get Kyphoplasty Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Kyphoplasty Surgery in UAE
Kyphoplasty Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Kyphoplasty is a minimally invasive vertebral augmentation procedure that restores vertebral body height, corrects kyphotic deformity, and eliminates debilitating pain caused by osteoporotic or pathological compression fractures — achieving clinically significant pain relief in over 90% of appropriately selected patients within 48 hours of the procedure. International patients travel to India and the UAE with GAF Healthcare to access world-class orthopedic spine centers staffed by fellowship-trained interventional spine surgeons, at a fraction of the cost charged in Western countries, with no compromise on imaging technology, implant quality, or post-procedural rehabilitation standards.
Hospital Stay: 1–2 days • Total Stay in Country (Fit-to-Fly): 1–2 weeks • Success Rate: 90–95%
What Is It?
Vertebral compression fractures (VCFs) occur when one or more vertebral bodies collapse under axial load, most commonly in the thoracic (T6–T12) and thoracolumbar junction (T12–L2) regions. In osteoporotic patients, this collapse can occur spontaneously or after minor trauma; in oncology patients, lytic metastases from breast, lung, prostate, or multiple myeloma destroy trabecular architecture and precipitate pathological fracture. The resulting loss of anterior vertebral height creates a wedge deformity that progressively shifts the spine's center of gravity anteriorly, generating a compensatory hyperkyphosis. Clinically, patients experience severe axial back pain aggravated by positional changes, reduced mobility, progressive height loss, restrictive pulmonary mechanics from thoracic cage distortion, and — in severe cases — neurological compromise from bony retropulsion into the spinal canal.
The standard of care for acute, painful VCFs unresponsive to 4–6 weeks of conservative management (analgesics, bracing, physiotherapy) is percutaneous vertebral augmentation. Kyphoplasty — formally termed balloon-assisted vertebroplasty or percutaneous kyphoplasty (PKP) — represents the current gold standard within this category. Unlike vertebroplasty, in which bone cement is injected directly into the collapsed body under high pressure, kyphoplasty first deploys an inflatable bone tamp (IBT) bilaterally within the vertebral body. Controlled inflation of the IBT on a manometer-guided pressure system creates a contained cavity and simultaneously elevates the fractured endplates, restoring lost vertebral height by an average of 34–47% according to the FREE and KAVIAR trial datasets. The cavity is then filled under low pressure with polymethylmethacrylate (PMMA) or — in younger or oncology patients — with calcium phosphate cement, dramatically reducing the risk of cement extravasation compared to vertebroplasty.
At GAF Healthcare partner institutions in India (Mumbai, Delhi, Bangalore, Chennai, Hyderabad) and the UAE (Dubai, Abu Dhabi), kyphoplasty is performed under biplane digital subtraction fluoroscopy or O-arm intraoperative CT guidance, ensuring real-time three-dimensional visualization of cement fill and immediate detection of any venous or epidural leakage. Surgeons are trained at ISASS, SMISS, and AO Spine–affiliated programs, and implant systems used include those from Medtronic (KyphX), Stryker (Vessel-X), and DePuy Synthes (Confidence Spinal System) — the same platforms used at Mayo Clinic and the Hospital for Special Surgery (HSS) in New York.
Candidates
• ELIGIBLE PATIENTS:
• Acute or subacute painful osteoporotic VCFs (typically within 6 weeks to 6 months of fracture onset, confirmed by MRI bone edema on STIR sequences)
• Pathological VCFs secondary to spinal metastases or multiple myeloma with preserved posterior vertebral wall integrity
• Painful VCFs causing significant functional disability (VAS pain score ≥ 5/10) refractory to minimum 4–6 weeks of structured conservative therapy
• Patients with Genant Grade 1–3 vertebral height loss (20–40%, 40–66%, >66%) confirmed on lateral spine radiograph and MRI
• Fracture levels T4–L5 with intact posterior cortex (no significant spinal canal compromise)
• Osteoporosis confirmed by DXA scan T-score ≤ −2.5 at the affected level
• Oncology patients with life expectancy > 3 months and adequate bone mineral density for cement anchorage
• REQUIRED DIAGNOSTIC WORKUP BEFORE PROCEDURE:
• MRI thoracolumbar spine with STIR and T1/T2 sequences (mandatory — confirms acute fracture, bone marrow edema, and rules out posterior wall disruption or epidural disease)
• Plain radiographs (AP and lateral) of full thoracic and lumbar spine
• CT scan of the affected vertebra(e) for cortical integrity mapping and surgical planning
• DXA bone mineral density scan
• Pre-operative blood panel: CBC, CMP, coagulation profile (PT/INR/aPTT), ESR, CRP
• Bone-specific ALP, serum PTH, Vitamin D25-OH levels (to guide concurrent osteoporosis pharmacotherapy)
• In oncology patients: Bone scintigraphy or whole-body PET-CT (18F-FDG) to characterize metastatic burden; serum protein electrophoresis (SPEP) and free light chains if myeloma suspected; biopsy of the affected vertebra if primary tumor unknown (can be performed concurrent with kyphoplasty)
• ECG and cardiopulmonary risk assessment (Goldman Cardiac Risk Index, RCRI scoring); pulmonary function tests if thoracic kyphosis is severe
• Anesthesia fitness evaluation (ASA classification)
• CONTRAINDICATIONS:
• Acute burst fracture with significant posterior cortex disruption and spinal canal compromise (>25–30% canal narrowing) — requires open decompression and instrumented fusion instead
• Active spinal or systemic infection (osteomyelitis, diskitis, bacteremia) — absolute contraindication to cement implantation
• Uncorrectable coagulopathy (INR > 1.5, platelets < 50,000/μL) not bridgeable pre-operatively
• Allergy to PMMA cement or iodinated contrast medium (relative — cement-free calcium phosphate alternatives or pre-medication protocols may apply)
• Asymptomatic or minimally symptomatic VCF adequately managed with conservative care
• Fracture with complete vertebra plana (total height loss <4 mm) where cavity creation is mechanically impossible
• Neurological deficit secondary to bony retropulsion — requires surgical decompression before or instead of augmentation
• Patients with isolated radicular pain without significant axial vertebral fracture pain
Procedure
STANDARD BILATERAL PERCUTANEOUS KYPHOPLASTY (PKP — Gold Standard):
Performed under general anesthesia or conscious sedation (MAC) with the patient prone on a Jackson radiolucent table. Under biplane fluoroscopic guidance, bilateral transpedicular access needles (11–13 gauge) are introduced into the fractured vertebral body — one through each pedicle — using a fluoroscopically verified extrapedicular or transpedicular trajectory depending on the thoracic vs. lumbar level. Working cannulas are advanced and a bone tamp channel is drilled. Inflatable bone tamps (IBTs) — radiopaque balloon devices rated to 400 psi — are inserted bilaterally and inflated incrementally under manometer control, elevating collapsed endplates and creating a contained, walled-off cavity. IBTs are then deflated and removed. Low-viscosity or high-viscosity PMMA cement (e.g., Confidence Spinal System, KyphX HV-R) is prepared and injected under continuous fluoroscopic visualization in a doughy phase to minimize extravasation risk. Cement fill volume typically ranges 3–8 mL per level. Bilateral approach provides more symmetric height restoration and superior biomechanical load distribution compared to unilateral access.
UNILATERAL KYPHOPLASTY (Minimally Invasive Variant):
Used for select lumbar levels where a parapedicular or unilateral extrapedicular approach grants sufficient access to the entire vertebral body. Reduces operative time by approximately 30%, lowers radiation exposure, and decreases pedicle violation risk. Outcome data from the VERTOS IV and STIC-2 studies support non-inferiority in pain relief vs. bilateral approach for single-level thoracolumbar fractures.
O-ARM / INTRAOPERATIVE CT-GUIDED KYPHOPLASTY:
At premium partner centers in India and the UAE, the O-arm 3D imaging system (Medtronic) combined with StealthStation navigation enables real-time, cone-beam CT verification of pedicle screw trajectories and cement fill extent. This is particularly critical for upper thoracic fractures (T4–T8) where pedicle anatomy is narrow and fluoroscopic visualization is limited by shoulder overlap. Navigation reduces pedicle breach rates from 8.5% (fluoroscopy-alone) to <2% and cement leakage rates from 11% to <4%.
ROBOTIC-ASSISTED KYPHOPLASTY:
Select centers at GAF Healthcare partner hospitals in Dubai and Mumbai deploy Mazor X Stealth Edition robotic guidance for multilevel kyphoplasty — enabling sub-millimeter accuracy in needle placement, especially valuable in severely osteoporotic or anatomically distorted vertebrae. The robotic arm holds the access needle on a pre-planned trajectory, eliminating freehand error during pedicle entry.
VESSEL-X / RADIOFREQUENCY-TARGETED VERTEBRAL AUGMENTATION (RF-TVA — StabiliT System):
A next-generation technique where ultra-high-viscosity cement (UHVC) is delivered via radiofrequency energy to precisely control cement viscosity at point of injection. This eliminates the need for a balloon tamp while still achieving cavity formation through controlled cement pressurization. Cement extravasation rates are reduced to <1% in published series (Palussière et al., 2012). Available at select centers in the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai).
KYPHOPLASTY WITH CONCURRENT SPINAL CORD STIMULATOR IMPLANTATION:
For patients with multilevel disease and residual neuropathic pain after augmentation, SCS trial can be staged at the same admission.
KYPHOPLASTY IN ONCOLOGY PATIENTS — SPECIAL PROTOCOL:
• Calcium phosphate cement (CPC) preferred over PMMA in younger patients (< 65 years) with pathological fractures, as CPC is resorbable and theoretically permits future surgical revision
• Simultaneous CT-guided biopsy of the affected vertebra during kyphoplasty provides tissue diagnosis without a second procedure
• Post-procedure radiation therapy (SBRT/SABR) can be initiated as early as 2–4 weeks post-cement curing without compromising cement integrity
• Coordination with medical oncology for concurrent bisphosphonate (zoledronic acid) or denosumab therapy to reduce skeletal-related events
Cost of Kyphoplasty Surgery: India vs. UAE
The cost of kyphoplasty varies significantly by destination, number of vertebral levels treated, anesthetic approach, and imaging technology used intraoperatively. India offers world-class outcomes at the lowest global price point for this procedure — approximately 50–65% less than equivalent care in the UAE — while the UAE delivers a premium clinical environment with luxury hospitality infrastructure and exceptional accessibility for patients from the GCC, Africa, and Europe. Both destinations offer implant brands and surgeon training identical to those available in the United States, United Kingdom, or Germany.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $3,500 – $6,500 | ~55% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $8,000 – $14,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PRE-OPERATIVE PHASE (Days −7 to −1):
• Day −7 to −5: Remote consultation with GAF Healthcare-affiliated spine surgeon via teleconsultation. Patient uploads MRI, CT, DXA, and blood reports to the GAF Healthcare secure portal for pre-screening. Surgeon confirms candidacy, plans approach (bilateral/unilateral, fluoroscopy/O-arm, cement type), and provides a personalized cost estimate.
• Day −3: Patient arrives in India or UAE. GAF Healthcare representative meets at airport and transfers to partner hotel or hospital guest house.
• Day −2 to −1: In-person specialist consultation. Repeat or confirmatory imaging performed locally if required. Pre-anesthesia assessment (ECG, echo if >60 years or cardiac history, pulmonary function test if indicated). Coagulation profile verified; anticoagulants (warfarin, clopidogrel, rivaroxaban) managed per bridge protocol — typically held 5–7 days pre-operatively. NPO (nothing by mouth) from midnight before procedure. Skin preparation and surgical site marking.
PROCEDURE DAY (Day 0):
• Patient admitted to hospital day-surgery or inpatient unit.
• IV access established; prophylactic antibiotics administered (cefazolin 2g IV) within 60 minutes of incision per SCIP protocol.
• Anesthesia induction: general anesthesia (preferred for multilevel, anxious, or non-cooperative patients) or IV conscious sedation/MAC for single-level procedures in cooperative patients.
• Patient positioned prone on Jackson table; pressure points padded; intraoperative fluoroscopic landmarks confirmed.
• Bilateral transpedicular needle insertion, IBT inflation under manometer control, cavity creation confirmed on biplane fluoroscopy or O-arm CT.
• Cement mixing, viscosity check, and injection under continuous fluoroscopy; lateral and AP views confirm fill pattern and rule out leakage.
• Needles withdrawn after cement polymerization (approximately 8–12 minutes); puncture sites closed with sterile steri-strips (no sutures required).
• Total operative time: 45–90 minutes for single-level; 90–150 minutes for two to three levels.
• Patient transferred to recovery room; neurological assessment (lower limb motor and sensory check) performed immediately upon emergence from anesthesia.
POST-OPERATIVE PHASE — HOSPITAL (Day 0–2):
• Patient mobilized to sitting position within 2–4 hours of procedure completion — this is a defining advantage of kyphoplasty over open spinal surgery.
• Pain assessment at 4, 8, and 24 hours using VAS scale; majority of patients report ≥50% pain reduction by the morning after surgery.
• Neurological observations every 2–4 hours for 24 hours.
• IV antibiotics continued for 24 hours; transition to oral analgesia (NSAIDs + acetaminophen; opioids only if required).
• Upright chest X-ray performed at 24 hours to rule out cement embolism (rare).
• Physiotherapy assessment on Day 1: supervised ambulation, posture correction, transfer technique training.
• Discharge on Day 1 (day-surgery cases) or Day 2 (inpatient, multilevel, or oncology cases).
EARLY RECOVERY — HOTEL / APARTMENT (Day 2–10):
• Patient stays in GAF Healthcare-arranged accommodation near the partner hospital with a designated nurse coordinator available on WhatsApp/call.
• Oral analgesics as required (typically weaned to as-needed by Day 5).
• Walking encouraged from Day 1; patients typically walk independently without a walker by Day 3–5.
• Avoid bending, lifting >2–3 kg, or twisting for the first 6 weeks.
• Osteoporosis pharmacotherapy initiated or optimized: bisphosphonates (alendronate, zoledronic acid), or anabolic agents (teriparatide/abaloparatide) if high fracture risk; calcium 1200 mg/day + Vitamin D3 2000 IU/day supplemented.
• Follow-up X-ray (lateral thoracolumbar spine) at Day 7–10 post-procedure to confirm maintained cement position and vertebral height.
• Surgeon teleconsult at Day 7.
FIT-TO-FLY ASSESSMENT (Day 10–14):
• Standard international flight (economy or business class) is typically cleared at 10–14 days post-procedure.
• FIT-TO-FLY criteria: independent ambulation without walking aid, VAS pain ≤ 3/10 at rest, no signs of cement leakage, no wound complications, anticoagulants safely resumed if applicable.
• For long-haul flights (>6 hours), compression stockings and hourly ambulation in the aisle are mandatory to reduce DVT risk in a post-procedural patient.
• GAF Healthcare provides a medical travel clearance letter and a procedure summary report (including fluoroscopy images, cement brand, volume injected per level, and post-operative imaging) for the patient's home physician.
LONG-TERM RECOVERY MILESTONES:
• Week 2–6: Light walking, swimming (after wound healing), gradual return to ADLs
• Week 6–12: Formal physiotherapy program including core strengthening, balance training, and progressive resistance exercises to reduce re-fracture risk at adjacent levels
• Month 3: Repeat DXA to assess BMD response to pharmacotherapy; spine radiograph to assess adjacent-level stability
• Month 6–12: Return to low-impact recreational activities; annual spine imaging in osteoporotic patients to monitor for new VCFs
Risks & Considerations
Kyphoplasty is one of the safest image-guided spinal procedures with an overall complication rate below 3% in high-volume centers, but patients must be informed of specific risks before consenting. Cement leakage (extravasation) into the paravertebral veins, disk space, or epidural space is the most commonly reported adverse event, occurring in approximately 4–9% of cases under fluoroscopy guidance and < 2% with O-arm or RF-TVA systems; the vast majority of leaks are clinically silent, but epidural cement extravasation can cause new radiculopathy or, rarely, cord compression requiring emergency decompression. Cement pulmonary embolism — migration of PMMA through paravertebral veins to the pulmonary vasculature — is rare (incidence < 0.6%) but potentially life-threatening; intraoperative monitoring and low-pressure injection technique are the primary safeguards. Pedicle fracture during IBT inflation is reported in 1–2% of cases with severely osteoporotic bone and mandates real-time pressure monitoring. Infection (discitis, osteomyelitis) is extremely rare (<0.1%) given the percutaneous nature of the procedure but carries serious consequences; prophylactic antibiotics and sterile technique are non-negotiable. Adjacent-level vertebral fracture — the most debated long-term concern — occurs in 12–20% of patients within 12 months of index kyphoplasty, likely reflecting underlying osteoporotic bone fragility rather than a mechanical cement-stiffness effect; this underscores the necessity of concurrent pharmacological osteoporosis treatment. Anesthesia-related risks (aspiration, cardiovascular events) are managed through thorough pre-operative risk stratification using ASA classification, the Goldman Cardiac Risk Index, and RCRI scoring. Deep vein thrombosis and pulmonary embolism risk is low due to the short operative time and immediate mobilization protocol but is heightened in oncology patients, who require pharmacological VTE prophylaxis (LMWH) initiated 24 hours post-procedure. Neurological deterioration (new motor deficit, bladder dysfunction) secondary to cement or instrument injury is the most feared complication but occurs in < 0.1% of cases at experienced centers.
Top Hospitals for Kyphoplasty Surgery
Frequently Asked Questions — Kyphoplasty Surgery
The all-inclusive cost of kyphoplasty in India at a JCI- or NABH-accredited hospital partner of GAF Healthcare typically ranges from USD 3,500 to USD 6,500 for a single-level procedure, depending on the number of vertebral levels treated, the imaging technology used (standard fluoroscopy vs. O-arm CT navigation), and the specific cement system selected. This includes surgeon fees, anesthesia, the hospital stay of 1–2 nights, intraoperative implants (IBT balloon and PMMA or CPC cement), and standard post-operative medications. In the UAE — at JCI-accredited or DHA-licensed hospitals in Dubai and Abu Dhabi — the equivalent procedure is priced between USD 8,000 and USD 14,000, reflecting higher facility overhead, premium nursing ratios, and luxury hospitality infrastructure. In practical terms, India offers the same surgical technique, the same implant brands (Medtronic KyphX, Stryker Vessel-X, DePuy Confidence), and similarly trained fellowship surgeons at approximately 50–65% lower cost. The UAE destination is optimal for patients from the GCC or Africa who prefer geographic proximity, a shorter travel distance, and a premium concierge clinical environment. GAF Healthcare provides a fully itemized, no-surprise cost estimate for both destinations before the patient commits to travel.
The vast majority of kyphoplasty patients treated at GAF Healthcare partner hospitals are cleared for international air travel within 10 to 14 days of their procedure. Unlike open spinal fusion surgery — which may require 4–8 weeks before flying — kyphoplasty is a percutaneous, minimally invasive procedure with no surgical incision, no muscle stripping, and no spinal instrumentation, allowing patients to mobilize independently within 4–6 hours of surgery and return to near-normal ambulation by Day 3–5. The fit-to-fly assessment at Day 10–14 confirms four criteria: independent ambulation without a walking aid, VAS pain ≤ 3/10 at rest, absence of any signs of cement leakage or neurological compromise on clinical examination, and safe resumption of any anticoagulant medications that were held pre-operatively. For patients undergoing multilevel kyphoplasty (two or three levels), or those with complex oncology-related fractures, the stay may extend to 2–3 weeks to allow adequate pain optimization and a confirmatory lateral spine radiograph. GAF Healthcare provides a formal medical travel clearance letter (fit-to-fly certificate) and a complete procedure summary for the patient's airline and home physician. For long-haul flights exceeding 6 hours, patients are advised to fly business class or premium economy to allow reclining, and to wear graduated compression stockings and ambulate in the aisle every 60–90 minutes to reduce DVT risk.
Kyphoplasty achieves clinically meaningful pain relief — defined as a reduction of ≥50% on the Visual Analog Scale (VAS) — in 90 to 95% of appropriately selected patients with acute osteoporotic or pathological vertebral compression fractures. This success rate is supported by Level I randomized controlled trial evidence, including the FREE Trial (Wardlaw et al., Lancet 2009), which demonstrated statistically significant improvements in SF-36 physical component scores, back pain VAS, and quality-adjusted life years at 12 and 24 months versus conservative management. Vertebral height restoration averages 34–47% of lost height when the procedure is performed within 6 weeks of fracture onset, and the benefit diminishes for fractures older than 4–6 months where endplate mobility is reduced. In oncology patients with pathological fractures, pain relief rates of 85–90% are reported, though durability depends on the natural history of the underlying malignancy and the concurrent use of systemic therapy and radiation. Neurological outcomes — prevention of progressive kyphotic deformity, avoidance of respiratory compromise, and maintenance of ambulatory independence — represent additional success parameters beyond pain alone. Patients at GAF Healthcare partner centers benefit from high surgical volume (centers performing >200 kyphoplasty procedures annually), intraoperative O-arm or fluoroscopic quality controls, and immediate access to interventional radiology and spine surgical backup in the rare event of a complication, all of which contribute to outcomes consistent with or exceeding published global benchmarks.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides an integrated, end-to-end medical travel support system so that patients focus exclusively on recovery rather than administrative complexity.
VISA & ENTRY DOCUMENTATION — INDIA: International patients traveling to India for kyphoplasty are eligible for the Indian e-Medical Visa (e-MV), which is processed entirely online within 72 hours and permits a stay of up to 60 days (extendable to 180 days if required). GAF Healthcare's visa coordination team prepares and reviews the complete application package, including the official medical invitation letter from the partner hospital — a mandatory document for e-MV approval — and submits it on the patient's behalf. Companion/attendant visas (e-Medical Attendant Visa) are arranged simultaneously for up to two family members accompanying the patient.
VISA & ENTRY DOCUMENTATION — UAE: Patients from over 120 countries, including the GCC, EU, UK, USA, Canada, and Australia, receive visa-free entry or a visa-on-arrival for the UAE (valid 30–90 days depending on nationality). Patients from other countries requiring a pre-arrival UAE visa benefit from GAF Healthcare's relationships with approved medical tourism facilitators registered with the Dubai Health Authority (DHA) and the Abu Dhabi Department of Health, who can facilitate medical visa NOC letters and expedited processing. UAE visas are typically issued within 3–5 working days.
AIRPORT TRANSFERS: GAF Healthcare arranges private, wheelchair-accessible airport-to-hospital and hospital-to-accommodation transfers for all patients. Post-procedure, patients with acute VCF pain require a comfortable, suspension-optimized vehicle; our partner fleet uses Mercedes V-Class or equivalent vehicles with orthopedic seating support.
ACCOMMODATION: Patients and their attendants are accommodated in GAF Healthcare-vetted serviced apartments or partner hotels within 5–15 minutes of the treating hospital. Rooms are selected for ground-floor or elevator access, firm mattresses (clinically preferable post-kyphoplasty), and proximity to pharmacies and diagnostic centers. Meals — including prescribed dietary adjustments for calcium-rich or anti-inflammatory nutrition — can be arranged through the accommodation's kitchen or through GAF Healthcare's meal delivery partners.
DEDICATED PATIENT COORDINATORS & TRANSLATORS: Each patient is assigned a named GAF Healthcare Patient Success Manager (PSM) who is reachable 24/7 via WhatsApp, phone, and email from the moment of inquiry through to discharge and fit-to-fly clearance. Professional medical translators are available for Arabic, Russian, French, Swahili, Bengali, and other major languages — present at all clinical consultations to ensure complete informed consent and post-operative instruction comprehension.
CLINICAL FOLLOW-UP & TELEMEDICINE: Post-discharge, the treating spine surgeon conducts scheduled video teleconsultations at Day 7, Week 4, and Month 3. All imaging, operative reports, and discharge summaries are delivered in a structured PDF dossier formatted for the patient's home physician, including implant lot numbers, cement brand and volume, and a recommended follow-up protocol.